VXRT – Vaxart, Inc.
Vaxart, Inc. - Common StockVXRT
$0.4945Name : Vaxart, Inc. - Common Stock
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $112,856,280.00
EPSttm : -0.26
Vaxart, Inc. - Common Stock
$0.4945
7.14%$0.038Float Short %
9.53
Margin Of Safety %
Put/Call OI Ratio
0.04
EPS Next Q Diff
0.01
EPS Last/This Y
0.04
EPS This/Next Y
-0.05
Price
0.49
Target Price
4.67
Analyst Recom
1
Performance Q
8.21
Relative Volume
0.67
Beta
1.19
Ticker: VXRT
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-06-02 | VXRT | 0.448 | 0.05 | 0.00 | 10975 |
| 2025-06-03 | VXRT | 0.4161 | 0.05 | 0.82 | 11023 |
| 2025-06-04 | VXRT | 0.4014 | 0.05 | 0.05 | 11001 |
| 2025-06-05 | VXRT | 0.3944 | 0.05 | 0.19 | 11303 |
| 2025-06-06 | VXRT | 0.405 | 0.05 | 0.25 | 11426 |
| 2025-06-09 | VXRT | 0.396 | 0.05 | 0.15 | 11472 |
| 2025-06-10 | VXRT | 0.3918 | 0.04 | 0.00 | 11341 |
| 2025-06-11 | VXRT | 0.51 | 0.04 | 0.06 | 11343 |
| 2025-06-12 | VXRT | 0.5268 | 0.04 | 0.01 | 14138 |
| 2025-06-13 | VXRT | 0.6863 | 0.04 | 0.02 | 14586 |
| 2025-06-16 | VXRT | 0.675 | 0.04 | 0.15 | 16488 |
| 2025-06-17 | VXRT | 0.5962 | 0.04 | 0.04 | 16602 |
| 2025-06-18 | VXRT | 0.6122 | 0.04 | 0.01 | 16769 |
| 2025-06-20 | VXRT | 0.58 | 0.04 | 0.01 | 16619 |
| 2025-06-23 | VXRT | 0.5658 | 0.04 | 0.23 | 12804 |
| 2025-06-24 | VXRT | 0.56 | 0.04 | 0.01 | 12945 |
| 2025-06-25 | VXRT | 0.5321 | 0.04 | 0.05 | 12965 |
| 2025-06-26 | VXRT | 0.5391 | 0.04 | 0.11 | 13499 |
| 2025-06-27 | VXRT | 0.4914 | 0.04 | 0.35 | 13552 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-06-02 | VXRT | 0.45 | -22.2 | - | -0.29 |
| 2025-06-03 | VXRT | 0.42 | -5.6 | - | -0.29 |
| 2025-06-04 | VXRT | 0.40 | -5.6 | - | -0.29 |
| 2025-06-05 | VXRT | 0.40 | -5.6 | - | -0.29 |
| 2025-06-06 | VXRT | 0.40 | -5.6 | - | -0.29 |
| 2025-06-09 | VXRT | 0.40 | -5.6 | - | -0.29 |
| 2025-06-10 | VXRT | 0.39 | -5.6 | - | -0.29 |
| 2025-06-11 | VXRT | 0.51 | -5.6 | - | -0.29 |
| 2025-06-12 | VXRT | 0.54 | -5.6 | - | -0.29 |
| 2025-06-13 | VXRT | 0.69 | -5.6 | - | -0.29 |
| 2025-06-16 | VXRT | 0.68 | -5.6 | - | -0.29 |
| 2025-06-17 | VXRT | 0.60 | -5.6 | - | -0.29 |
| 2025-06-18 | VXRT | 0.61 | -5.6 | - | -0.29 |
| 2025-06-20 | VXRT | 0.58 | -5.6 | - | -0.29 |
| 2025-06-23 | VXRT | 0.56 | -5.6 | - | -0.29 |
| 2025-06-24 | VXRT | 0.56 | -5.6 | - | -0.29 |
| 2025-06-25 | VXRT | 0.53 | -5.6 | - | -0.29 |
| 2025-06-26 | VXRT | 0.54 | -5.6 | - | -0.29 |
| 2025-06-27 | VXRT | 0.49 | -5.6 | - | -0.29 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-06-02 | VXRT | 1.67 | -23.52 | 6.46 |
| 2025-06-03 | VXRT | 1.67 | -23.52 | 6.46 |
| 2025-06-04 | VXRT | 1.67 | -23.52 | 6.46 |
| 2025-06-05 | VXRT | 1.67 | -23.52 | 6.46 |
| 2025-06-06 | VXRT | 1.67 | -23.52 | 6.46 |
| 2025-06-09 | VXRT | 1.67 | -23.52 | 6.46 |
| 2025-06-10 | VXRT | 1.67 | -23.52 | 6.46 |
| 2025-06-11 | VXRT | 1.67 | -23.52 | 6.60 |
| 2025-06-12 | VXRT | 1.67 | -23.52 | 6.60 |
| 2025-06-13 | VXRT | 1.67 | -23.52 | 6.60 |
| 2025-06-16 | VXRT | 1.67 | -23.52 | 6.60 |
| 2025-06-18 | VXRT | 1.67 | -23.52 | 6.60 |
| 2025-06-20 | VXRT | 1.67 | -23.52 | 6.60 |
| 2025-06-23 | VXRT | 1.67 | -23.52 | 6.61 |
| 2025-06-24 | VXRT | 1.65 | -23.52 | 6.61 |
| 2025-06-25 | VXRT | 1.65 | -23.52 | 6.61 |
| 2025-06-26 | VXRT | 1.65 | -23.52 | 9.53 |
| 2025-06-27 | VXRT | 1.65 | -23.52 | 9.53 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.07
Avg. EPS Est. Current Quarter
-0.1
Avg. EPS Est. Next Quarter
-0.07
Insider Transactions
1.65
Institutional Transactions
-23.52
Beta
1.19
Average Sales Estimate Current Quarter
2
Average Sales Estimate Next Quarter
2
Fair Value
Quality Score
24
Growth Score
39
Sentiment Score
5
Actual DrawDown %
98
Max Drawdown 5-Year %
-98.7
Target Price
4.67
P/E
Forward P/E
PEG
P/S
2.38
P/B
2.47
P/Free Cash Flow
EPS
-0.27
Average EPS Est. Cur. Y
-0.29
EPS Next Y. (Est.)
-0.34
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-122.63
Relative Volume
0.67
Return on Equity vs Sector %
-151.3
Return on Equity vs Industry %
-133.5
EPS 1 7Days Diff
EPS 1 30Days Diff
0.05
EBIT Estimation
Vaxart, Inc. - Common StockSector: Healthcare
Industry: Biotechnology
Employees: 105
Vaxart, Inc., a clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its vector-adjuvant-antigen standardized technology proprietary oral vaccine platform in the United States. The company's product pipeline includes norovirus vaccine, a bivalent oral tablet vaccine in Phase 2 clinical trial for the GI.1 and GII.4 norovirus strains; coronavirus vaccine, which is in Phase 2 clinical trial, for the treatment of SARS-CoV-2 infection; seasonal influenza vaccine, which is in Phase 2 clinical trial, to treat H1 influenza infection; and human papillomavirus therapeutic vaccine, which is in preclinical stage, that targets HPV-16 and HPV-18 for cervical cancers and precancerous cervical lesions. It has a license agreement with Altesa Biosciences, Inc. to develop and commercialize Vapendavir, a capsid-binding broad-spectrum antiviral. Vaxart, Inc. is headquartered in South San Francisco, California.
stock quote shares VXRT – Vaxart, Inc. Stock Price stock today
news today VXRT – Vaxart, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch VXRT – Vaxart, Inc. yahoo finance google finance
stock history VXRT – Vaxart, Inc. invest stock market
stock prices VXRT premarket after hours
ticker VXRT fair value insiders trading